The Politics of Patents and Drugs in Brazil and Mexico
The Industrial Bases of Health Policies
Bibliographic Data
| ID | 6141080 |
|---|---|
| Authors | Kenneth C Shadlen (0000-0003-4010-4835, corresponding author) |
| Year | 2009 |
| Volume | 42 |
| Issue | 1 |
| Pages | 41-58 |
| Publication date | 2009-10-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Comparative Politics (JOURNAL) |
| Journal identifiers | ISSN: 0010-4159 • E-ISSN: 2151-6227 |
| Publisher | Comparative Politics CUNY (PUBLISHER) |
| DOI | 10.5129/001041509x12911362972791 |
| OpenAlex | W2009615969 |
| Language | EN |
| Citations received | 20 |
| References cited | 12 |
After introducing pharmaceutical patents in the 1990s, Brazil subsequently adjusted the patent system to ameliorate its effects on drug prices, while Mexico introduced measures that reinforce and intensify these effects. The different trajectories are due to the nature of the actors pushing for reform and the patterns of coalitional formation and political mobilization. In Brazil government demand for expensive, patented drugs made health-oriented patent reform a priority. The existence of an autonomous local pharmaceutical sector allowed the Ministry of Health to build a supportive coalition. In Mexico government demand made reforms less urgent, and transformations of the pharmaceutical sector allowed patent-holding firms to commandeer a reform project. The existence of indigenous pharmaceutical capacities can broaden the political coalitions underpinning health reforms
Political science · Politics · Biotechnology and Related Fields · Intellectual Property and Patents · Law · Pharmaceutical Economics and Policy · Public Administration
Asserting The Primacy of Health Over Patent Rights
Technology in Latin America’s Past and Present
Organizing Twenty-First-Century Activism
From Situations of Dependency to Globalized Social Democracy
Biomedical Innovation and the Geopolitics of Patenting
How to Study Global Lawmaking
The Impact of Patents on Innovation, Technology Transfer and Health
The Mexican Exception
State capacity and intellectual property regimes
The political economy of compulsory licensing
Intellectual Property, Access to Medicines, and Health
Narrowing the Gaps in Global Disputes
Developmental states, civil society, and public health
Ideas and Leadership in the Crafting of Alternative Industrial Policies
Biopharmaceuticals in Latin America
Innovation as a political process of development
Complex norm localization
Pharmaceuticals and the Global South
Changing Global Norms through Reactive Diffusion
The Political Contradictions of Incremental Innovation
Intellectual Property and Public Health
Unacceptable Costs
The challenge by domestic enterprises to the transnational corporations' domination
Brazil and Access to HIV/Aids Drugs
Patents and pills, power and procedure
Political Bias in Policy Convergence
When Does Diffusion Matter? Explaining the Spread of Structural Pension Reforms Across Nations
The Political Economy of Aids Treatment
Neoliberal Economists and Capital Account Liberalization in Emerging Markets
Orphaned by Democracy
Public Production of Anti-Retroviral Medicines in Brazil, 1990-2007
The Activist State
| Unique citing works | 20 |
|---|---|
| Citations per year | 1,18 |
| Citation span | 2009 - 2025 (17) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 20 |